| Property | Value |
|---|
|
?:abstract
|
-
SARS-CoV-2 was identified as a new virus in January 2020 following reports of pneumonia of unknown aetiology from China. Since then, the virus has spread rapidly throughout the world. While evidence accumulates on the collateral damage to children as a result of system changes, SARS-CoV-2 appears to rarely cause serious illness in younger age groups. However, the emergence of an inflammatory condition associated with COVID-19 has complicated initial assessment. We present a summary of how the virus has affected children with a synopsis of testing and treatment to help acute paediatricians make informed decisions.
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:doi
|
-
10.1136/archdischild-2020-320161
|
|
?:doi
|
|
|
?:journal
|
-
Archives_of_disease_in_childhood._Education_and_practice_edition
|
|
?:license
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Fifteen-minute consultation: Does this child have COVID-19 (and does it matter)?
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}